New study: Montreal researchers identify three drugs that could reduce mortality in severely ill COVID-19 patients

Researchers from the RI-MUHC and the McGill Genome Centre examine differences in ICU patients who recovered or died from COVID-19 and identify candidate drugs to treat severe disease.

Related Keywords

Montreal ,Quebec ,Canada ,Canadian ,Marianna Orlova ,Pubudum Nawarathna ,Guillaume Bourque ,Pauline Cassart ,Erwin Schurr ,Fabienne Landry ,Matthew Pellan Cheng ,Cynthia Lee ,Donaldc Vinh ,Erwin Schurr David Langlais ,David Langlais ,Mathieu Bourgey Vinicius ,Mathieu Bourgey ,Mcgill Genome Centre ,Emergency Fund ,Immunity Initiative ,Canadian Institutes Of Health Research ,Professor At Mcgill Department Of Medicine ,Mcgill University Interdisciplinary Infection ,Mcgill University ,Professor In Mcgill School Of Biomedical Sciences ,Canadian Centre For Computational Genomics ,Immunity In Global Health Program ,Mcgill University Health Centre ,Research Institute ,Canadian Centre ,Computational Genomics ,Science Advances ,Vinicius Fava ,Peripheral Blood Mononuclear Cells ,Assistant Professor ,Biomedical Sciences ,Infectious Diseases ,Global Health Program ,Canadian Institutes ,Health Research ,